Invesco Ltd. Grows Position in Henry Schein, Inc. (NASDAQ:HSIC)

Invesco Ltd. increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,963,409 shares of the company’s stock after purchasing an additional 17,552 shares during the quarter. Invesco Ltd.’s holdings in Henry Schein were worth $343,468,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Olstein Capital Management L.P. boosted its stake in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after purchasing an additional 16,000 shares during the period. Private Management Group Inc. boosted its stake in shares of Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. purchased a new position in shares of Henry Schein during the 4th quarter worth about $417,000. Savant Capital LLC boosted its stake in shares of Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock worth $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock worth $1,113,000 after purchasing an additional 3,650 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on HSIC. StockNews.com raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Wednesday. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Five research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Trading Up 5.5 %

NASDAQ HSIC opened at $66.16 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.22 billion, a PE ratio of 27.23, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a 50 day moving average price of $72.55 and a 200 day moving average price of $72.32. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.66 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.